Table 1

Clinical, laboratory and procedural characteristics of the investigated patients

CharacteristicsNo CCBs (n=109)CCBs (n=53)p Value
Age, years64±1269±100.04
Male sex66 (60.6)32 (60.4)0.98
Medical history
 Previous MI51 (46.8)9 (17)< 0.001
 Previous TIA/stroke11 (10.1)11 (20.8)0.06
 Hypertension99 (90.8)53 (100)0.02
 Hypercholesterolaemia100 (91.7)50 (94.3)0.55
 Diabetes mellitus28 (25.7)27 (50.9)0.001
 Smoking45 (41.3)20 (37.7)0.67
Laboratory data
 Platelet count, G/l216±59216±530.95
 Serum creatinine, mg/dl1.05±0.271.17±0.410.07
 C-reactive protein, mg/dl1.92±2.121.94±2.240.96
Procedure
 Stent implantation109 (100)53 (100)1.0
 Peripheral53 (48.6)40 (75.5)0.001
 Coronary45 (41.3)8 (15.1)0.001
 Carotid11 (10.1)5 (9.4)0.9
 Number of stents/patient2±12±10.52
Medication pre-intervention
 Clopidogrel109 (100)53 (100)1.0
 Aspirin109 (100)53 (100)1.0
 Statins106 (97.2)51 (96.2)0.72
 ACE inhibitors79 (72.5)33 (62.3)0.19
 Angiotensin receptor blockers23 (21.1)17 (32.1)0.13
 β Blockers81 (74.3)32 (60.4)0.07
 Proton pump inhibitors69 (63.3)27 (50.9)0.13
  • Continuous data are shown as mean±SD. Dichotomous data are shown as n (%).

  • CCB, calcium-channel blocker; MI, myocardial infarction; TIA, transient ischaemic attack.